Impact of intravenous ferric carboxymaltose on physical performance and patient-reported outcomes in elderly patients with non-dialysis CKD, mild anemia, and iron deficiency: A pilot study

Background: Iron deficiency (ID) is highly prevalent in chronic kidney disease (CKD) and it's associated with poorer quality of life (QoL) and functional capacity. Intravenous iron therapy is limited to CKD patients with ID and anemia to avoid/delay the need or reduce the dose of erythropoiesis-stim...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Maria Jesús Puchades, Juan Casas, Julio Nuñez, Elena Gimenez-Civera, Boris Gonzales, Marco Montomoli, Rafael de la Espriella, Miguel Gonzalez-Rico, Isidro Torregrosa, Carlos J. Peña, Aleix Cases, Jose Luis Gorriz
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2026-02-01
Цуврал:	Nefrología (English Edition)
Нөхцлүүд:	Anemia Déficit de hierro Hierro carboximaltosa Enfermedad renal crónica Test de la marcha de 6 min Calidad de vida
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2013251426000428
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!